Braking bad: blockade of inhibitory pathways improves interleukin-15 therapy. [electronic resource]
- Clinical cancer research : an official journal of the American Association for Cancer Research Dec 2010
- 5917-9 p. digital
Publication Type: Comment; Journal Article
1557-3265
10.1158/1078-0432.CCR-10-2658 doi
Animals Antibodies, Neutralizing--administration & dosage Antigens, CD--immunology Antigens, Differentiation--immunology Antineoplastic Combined Chemotherapy Protocols--therapeutic use CTLA-4 Antigen Cell Line, Tumor Disease Models, Animal Drug Evaluation, Preclinical Drug Synergism Immune Tolerance--drug effects Immunotherapy--methods Interleukin-15--therapeutic use Mice Models, Biological Neoplasm Metastasis Neoplasms--drug therapy Programmed Cell Death 1 Receptor Signal Transduction--drug effects Treatment Outcome